| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.78M | - | |
| VP | 79.5K | $715.6K | - | |
| VP | 67.4K | $606.5K | - | |
| VP | 65.1K | $585.7K | - | |
| VP | 56.3K | $506.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2020 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sale+OE | 10,054 | $14.98 | $150,608.92 | -68.4% | |
| Aug 26, 2020 | Demaree John | Chief Commercial Officer | Buy | 7,500 | $14.54 | $109,012.50 | New | |
| Aug 17, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 1,477 | $15.00 | $22,155.00 | -0.2% | |
| Aug 17, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 1,477 | $15.00 | $22,155.00 | -0.2% | |
| Jul 15, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 7,500 | $19.43 | $145,722.75 | -1.0% | |
| Jul 15, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 7,500 | $19.43 | $145,722.75 | -1.0% | |
| Jul 15, 2020 | Shah Jatin54 | EVP, Chief Medical Officer | Sale+OE | 589 | $19.46 | $11,461.94 | -1.3% | |
| Jul 10, 2020 | Shacham Sharon79 | President &CSO | Sale+OE | 15,000 | $19.27 | $289,026.21 | -0.8% | |
| Jul 10, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 15,000 | $19.27 | $289,026.21 | -0.8% | |
| Jun 22, 2020 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 7,500 | $20.00 | $150,000.00 | -1.0% |